Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Gilabert-Oriol R, Weng A, Mallinckrodt Bv, Melzig MF, Fuchs H, Thakur M.

Curr Pharm Des. 2014;20(42):6584-643. Review.

2.

Antibody-based therapeutics for the treatment of human B cell malignancies.

Baskar S, Muthusamy N.

Curr Allergy Asthma Rep. 2013 Feb;13(1):33-43. doi: 10.1007/s11882-012-0327-7. Review.

3.

Targeting malignant B cells with an immunotoxin against ROR1.

Baskar S, Wiestner A, Wilson WH, Pastan I, Rader C.

MAbs. 2012 May-Jun;4(3):349-61. doi: 10.4161/mabs.19870. Epub 2012 Apr 26.

4.

RAFT-synthesized graft copolymers that enhance pH-dependent membrane destabilization and protein circulation times.

Crownover E, Duvall CL, Convertine A, Hoffman AS, Stayton PS.

J Control Release. 2011 Oct 30;155(2):167-74. doi: 10.1016/j.jconrel.2011.06.013. Epub 2011 Jun 15.

5.

Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.

Du X, Beers R, Fitzgerald DJ, Pastan I.

Cancer Res. 2008 Aug 1;68(15):6300-5. doi: 10.1158/0008-5472.CAN-08-0461.

7.
8.
9.

Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells.

Wargalla UC, Reisfeld RA.

Proc Natl Acad Sci U S A. 1989 Jul;86(13):5146-50.

10.

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.

Till MA, Zolla-Pazner S, Gorny MK, Patton JS, Uhr JW, Vitetta ES.

Proc Natl Acad Sci U S A. 1989 Mar;86(6):1987-91.

11.

Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.

Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA.

Br J Cancer. 1990 Sep;62(3):410-4.

12.

Systemic immunotoxin therapy of cancer: advances and prospects.

Wawrzynczak EJ.

Br J Cancer. 1991 Oct;64(4):624-30. Review. No abstract available.

13.

Supplemental Content

Support Center